These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
4. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone. Caron V; Tajber L; Corrigan OI; Healy AM Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367 [TBL] [Abstract][Full Text] [Related]
5. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. Parikh T; Sandhu HK; Talele TT; Serajuddin AT Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566 [TBL] [Abstract][Full Text] [Related]
6. Spray drying of poorly soluble drugs from aqueous arginine solution. Ojarinta R; Lerminiaux L; Laitinen R Int J Pharm; 2017 Oct; 532(1):289-298. PubMed ID: 28890173 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying. Craye G; Löbmann K; Grohganz H; Rades T; Laitinen R Molecules; 2015 Dec; 20(12):21532-48. PubMed ID: 26633346 [TBL] [Abstract][Full Text] [Related]
8. Co-amorphization of atorvastatin by lisinopril as a co-former for solubility improvement. Li W; Song J; Li J; Li M; Tian B; He Z; Liu X; Fu Q Int J Pharm; 2021 Sep; 607():120971. PubMed ID: 34363915 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions. Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386 [TBL] [Abstract][Full Text] [Related]
10. Characterizing and Exploring the Differences in Dissolution and Stability Between Crystalline Solid Dispersion and Amorphous Solid Dispersion. Wang X; Zhang L; Ma D; Tang X; Zhang Y; Yin T; Gou J; Wang Y; He H AAPS PharmSciTech; 2020 Sep; 21(7):262. PubMed ID: 32975680 [TBL] [Abstract][Full Text] [Related]
11. Improved Dissolution Properties of Co-amorphous Probucol with Atorvastatin Calcium Trihydrate Prepared by Spray-Drying. Oyama S; Ogawa N; Kawai K; Iwai K; Yasunaga T; Yamamoto H Chem Pharm Bull (Tokyo); 2024; 72(2):190-199. PubMed ID: 38369345 [TBL] [Abstract][Full Text] [Related]
12. Tannic acid as a co-former in co-amorphous systems: Enhancing their physical stability, solubility and dissolution behavior. Fael H; Demirel AL Int J Pharm; 2020 May; 581():119284. PubMed ID: 32243965 [TBL] [Abstract][Full Text] [Related]
13. Investigating a Novel Hot Melt Extrusion-Based Drying Technique to Solidify an Amorphous Nanosuspension Using Design of Experiment Methodology. Gajera BY; Shah DA; Dave RH AAPS PharmSciTech; 2018 Nov; 19(8):3778-3790. PubMed ID: 30280356 [TBL] [Abstract][Full Text] [Related]
14. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan. Huang Y; Zhang Q; Wang JR; Lin KL; Mei X Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301 [TBL] [Abstract][Full Text] [Related]
15. [The development of co-amorphous drug systems]. Yao J; Shi NQ; Wang XL Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685 [TBL] [Abstract][Full Text] [Related]
17. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine. Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246 [TBL] [Abstract][Full Text] [Related]
18. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions. Paudel A; Loyson Y; Van den Mooter G J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268 [TBL] [Abstract][Full Text] [Related]
19. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying. Tian Y; Caron V; Jones DS; Healy AM; Andrews GP J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445 [TBL] [Abstract][Full Text] [Related]
20. [Study on the properties of felodipine solid dispersions prepared by different technologies]. Shi NQ; Zhang H; Zhang Y; Feng B; Li ZQ; Qi XR Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1067-1073. PubMed ID: 27987515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]